The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children
2008/03/18 by Calman A. MacLennan, Esther N. Gondwe, Chisomo L. Msefula +14 · 26 citations
Agricultural and Biological Sciences · Medicine · Biochemistry, Genetics and Molecular Biology · #Salmonella and Campylobacter epidemiology #Viral gastroenteritis research and epidemiology #Escherichia coli research studies
paper · pdf · doi:10.1172/jci33998
Abstract
Nontyphoidal strains of Salmonella (NTS) are a common cause of bacteremia among African children. Cell-mediated immune responses control intracellular infection, but they do not protect against extracellular growth of NTS in the blood. We investigated whether antibody protects against NTS bacteremia in Malawian children, because we found this condition mainly occurs before 2 years of age, with relative sparing of infants younger than 4 months old. Sera from all healthy Malawian children tested aged more than 16 months contained anti-Salmonella antibody and successfully killed NTS. Killing was mediated by complement membrane attack complex and not augmented in the presence of blood leukocytes. Sera from most healthy children less than 16 months old lacked NTS-specific antibody, and sera lacking antibody did not kill NTS despite normal complement function. Addition of Salmonella-specific antibody, but not mannose-binding lectin, enabled NTS killing. All NTS strains tested had long-chain lipopolysaccharide and the rck gene, features that resist direct complement-mediated killing. Disruption of lipopolysaccharide biosynthesis enabled killing of NTS by serum lacking Salmonella-specific antibody. We conclude that Salmonella-specific antibody that overcomes the complement resistance of NTS develops by 2 years of life in Malawian children. This finding and the age-incidence of NTS bacteremia suggest that antibody protects against NTS bacteremia and support the development of vaccines against NTS that induce protective antibody.
Cited by
- Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets
- Invasive non-Typhi Salmonella disease in Africa. [europepmc]
- Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. [europepmc]
- Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. [europepmc]
- Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. [europepmc]
- Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis. [europepmc]
- Classical labeling of bacterial pathogens according to their lifestyle in the host: inconsistencies and alternatives. [europepmc]
- A scalable method for O-antigen purification applied to various Salmonella serovars. [europepmc]
- Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion. [europepmc]
- Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines. [europepmc]
- Vaccines against invasive Salmonella disease: current status and future directions. [europepmc]
- Immunity to intestinal pathogens: lessons learned from Salmonella. [europepmc]
- The association between malaria and non-typhoid Salmonella bacteraemia in children in sub-Saharan Africa: a literature review. [europepmc]
- Protective host immune responses to Salmonella infection. [europepmc]
- Antimicrobial resistance and management of invasive Salmonella disease. [europepmc]
- Infection-related hemolysis and susceptibility to Gram-negative bacterial co-infection. [europepmc]
- Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. [europepmc]
- Modelling the Contributions of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal Salmonella Disease in Malawi. [europepmc]
- Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. [europepmc]
- Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout. [europepmc]
- Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa. [europepmc]
- Current perspectives on invasive nontyphoidal Salmonella disease. [europepmc]
- Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure. [europepmc]
- Humoral Immunity vs. Salmonella . [europepmc]
- Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface. [europepmc]
- Mucosal immune response in biology, disease prevention and treatment. [europepmc]
Related